Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSolGold Regulatory News (SOLG)

  • This share is currently suspended. It was suspended at a price of 27.95
  • There is currently no data for SOLG

Form 8.3

27 Feb 2026 15:25

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:

Millennium International Management LP

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

SolGold plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

26th February 2026

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

No

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

1p Ordinary (GB00B0WD0R35)

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

-

-

-

-

(2) Cash-settled derivatives:

31,429,332

1.043%

-

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

-

-

-

-

TOTAL:

31,429,332

1.043%

-

-

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchase/sale

Number of securities

Price per unit (GBP)

(b) Cash-settled derivative transactions

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

GB00B0WD0R35

Equity Swap

Reducing a Long Position

2,315

0.28 GBP

GB00B0WD0R35

Equity Swap

Reducing a Long Position

13,577

0.28 GBP

GB00B0WD0R35

Equity Swap

Reducing a Long Position

3,040,961

0.28 GBP

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

NONE

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

27th February 2026

Contact name:

Stephen Glasper

Telephone number:

+44 203 398 2166

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260227192458/en/

Copyright Business Wire 2026

Date   Source Headline
6th Mar 20247:00 amRNSCascabel CIPA
4th Mar 20247:00 amRNSMOU for Sustainable Hydro-Solar Energy at Cascabel
28th Feb 20247:00 amRNSSolGold Appoints New Directors
16th Feb 20247:00 amRNSCompletion of New Cascabel Pre-Feasibility Study
15th Feb 20247:00 amRNSHalf-year Report
22nd Jan 20247:00 amRNSCorporate Update
3rd Jan 202412:29 pmRNSBlock Listing Six Monthly Return
21st Dec 20237:00 amRNSResult of AGM
14th Dec 20238:34 amRNSReminder to Vote at AGM & Cascabel Update
8th Dec 20237:00 amRNSEspejo Project Update
5th Dec 20237:02 amRNSBlanca-Nieves Project Update
1st Dec 202312:37 pmRNSPorvenir Project Update
23rd Nov 20236:11 pmRNSNotice of AGM
23rd Nov 20235:32 pmRNSNotice of AGM
17th Nov 202311:46 amRNSDirector Changes
15th Nov 20237:00 amRNSQ1 Financial Report and MD&A
25th Oct 20237:00 amRNSSolGold Company Update
11th Oct 20233:45 pmRNSDirector/PDMR Shareholding
9th Oct 20233:37 pmRNSDirector/PDMR Shareholding
29th Sep 20237:00 amRNSAudited Full Year Results
20th Jul 20237:00 amRNSExploitation Agreement with Government of Ecuador
17th Jul 20237:00 amRNSInvestor Presentation
17th Jul 20237:00 amRNSRenewal for the Cascabel Project Concession
27th Jun 20237:00 amRNSBlock Listing Application
23rd Jun 20234:38 pmRNSDirector/PDMR Shareholding
16th Jun 202312:39 pmRNSTR-1: Notification of Major Holdings
15th Jun 20235:29 pmRNSInvestor Presentation
6th Jun 20234:06 pmRNSPCA Dealing
15th May 20237:00 amRNSThird-Quarter Financial Report and MD&A
11th May 20232:50 pmRNSShare Capital and Voting Rights
21st Apr 20236:08 pmRNSGrant of Options
17th Apr 20237:00 amRNSUpdated Share Capital and Voting Rights
6th Apr 20231:28 pmRNSHolding(s) in Company
20th Mar 20237:00 amRNSAppointment of CFO and CEO
3rd Mar 20235:35 pmRNSHolding(s) in Company
2nd Mar 20232:11 pmRNSHolding(s) in Company
2nd Mar 20232:10 pmRNSHolding(s) in Company
28th Feb 20235:22 pmRNSHolding(s) in Company
28th Feb 20234:30 pmRNSTotal Voting Rights
28th Feb 202310:38 amRNSHolding(s) in Company
28th Feb 202310:19 amRNSHolding(s) in Company
24th Feb 20231:49 pmRNSSolGold Completes Cornerstone Merger
22nd Feb 20232:51 pmRNSPublication of Prospectus
17th Feb 20237:00 amRNSCompany Update
14th Feb 20237:00 amRNSHalf-Yearly Financial Report and Quarterly MD&A
24th Jan 20237:00 amRNSCornerstone Acquisition Update
30th Dec 20227:00 amRNSUpdated Share Capital and Voting Rights
23rd Dec 20227:00 amRNSResults of the 2022 AGM
15th Dec 20224:44 pmRNSHolding(s) in Company
15th Dec 20228:49 amRNSLetter to Shareholders & Reminder to Vote at AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.